Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations

Molecular Imaging of Prostate Cancer: PET Radiotracers

(2012) Hossein Jadvar   AMERICAN JOURNAL OF ROENTGENOLOGY

The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006–2009) nationwide survey

(2012) Ryogo Minamimoto et al.   ANNALS OF NUCLEAR MEDICINE

Prospective Evaluation of 18F-NaF and 18F-FDG PET/CT in Detection of Occult Metastatic Disease in Biochemical Recurrence of Prostate Cancer

(2012) Hossein Jadvar et al.   CLINICAL NUCLEAR MEDICINE

International Variation in Prostate Cancer Incidence and Mortality Rates

(2012) Melissa M. Center et al.   EUROPEAN UROLOGY

Developing imaging strategies for castration resistant prostate cancer

(2011) Josef J. Fox et al.   ACTA ONCOLOGICA

Do androgens control the uptake of 18F-FDG, 11C-choline and 11C-acetate in human prostate cancer cell lines?

(2011) Kimy M. Emonds et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Assessment of PET Tracer Uptake in Hormone-Independent and Hormone-Dependent Xenograft Prostate Cancer Mouse Models

(2011) D. Kukuk et al.   JOURNAL OF NUCLEAR MEDICINE

The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level

(2010) Ryogo Minamimoto et al.   ANNALS OF NUCLEAR MEDICINE

Androgen stimulates glycolysis forde novolipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells

(2010) Jong-Seok Moon et al.   BIOCHEMICAL JOURNAL

Prognostic Value of Baseline [18F] Fluorodeoxyglucose Positron Emission Tomography and 99mTc-MDP Bone Scan in Progressing Metastatic Prostate Cancer

(2010) G. S. P. Meirelles et al.   CLINICAL CANCER RESEARCH

Preoperative detection of prostate cancer: A comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging

(2010) Haruo Watanabe et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Diffuse FDG Uptake in Acute Prostatitis

(2009) Pan-Fu Kao et al.   CLINICAL NUCLEAR MEDICINE

Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET

(2009) Hossein Jadvar   Nature Reviews Urology

[F-18]-fluorodeoxyglucose PET-CT of the normal prostate gland

(2008) Hossein Jadvar et al.   ANNALS OF NUCLEAR MEDICINE

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

(2008) Howard I. Scher et al.   JOURNAL OF CLINICAL ONCOLOGY

Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer

(2008) A. B. Apolo et al.   JOURNAL OF NUCLEAR MEDICINE

Relationship Between Cancer Type and Impact of PET and PET/CT on Intended Management: Findings of the National Oncologic PET Registry

(2008) B. E. Hillner et al.   JOURNAL OF NUCLEAR MEDICINE